1. © Copyright 2004 Frost & Sullivan. All Rights Reserved. Strategic Analysis of the U.S. Overactive Bladder and Stress Urinary Incontinence Emerging Markets Under-treated conditions create significant opportunities for enhanced medication therapies Healthcare Group “Underreporting of OAB and SUI and sub-optimal drug efficacy creates opportunities for new medications to make a mark by either satisfying unmet therapeutic needs or improving the side effect and safety profile.

2. © Copyright 2004 Frost & Sullivan. All Rights Reserved. Industry Trends Selective antimuscarinics and first medication therapy for SUI await final FDA approval Mass awareness initiatives for OAB and SUI underway Market focus on comorbidities that occur with overactive bladder and stress urinary incontinence Extensive pipeline medications which cover array of therapy options from unique drug delivery options to novel therapeutic targets

3. © Copyright 2004 Frost & Sullivan. All Rights Reserved. Key Features Frost & Sullivan Provides: Detailed insights into recent developments and trends Drivers, restraints, challenges, and strategic recommendations Analyst insights on ‘hot topics' and emerging applications in the OAB and SUI market Market sizing and competitive analysis Market forecasts and opportunity analysis Product analysis Comparative product analysis

4. © Copyright 2004 Frost & Sullivan. All Rights Reserved. What We Offer Coverage: The United States Proven methodology encompassing extensive primary and secondary data and research Focused information and analysis for business planning and strategic decision-making Credible data and analysis highlighting industry dynamics Critical insights into related industries covering the entire gamut of participants Key factors for successful business strategies

5. © Copyright 2004 Frost & Sullivan. All Rights Reserved. Who Will Benefit? Current Market Participants  Find out how you compare to the competition  Assess current and future drivers and restraints  Determine and exploit new market share opportunities New Entrants  Analyse challenges associated with the industry  Calculate time scales for strategy implementation  Position yourself to capitalize on the market’s unmet needs Investment Community  Determine which participants will outperform the competition  Analyze long-term strategies of companies developing therapies for OAB and SUI  Assess attractiveness of investing in the OAB and SUI market

6. © Copyright 2004 Frost & Sullivan. All Rights Reserved. Key Market Participants  Allergan  Antares Pharma  AstraZeneca  Auxilium Pharmaceuticals  Barr Laboratories  Dynogen Pharmaceuticals  Eli Lilly  GlaxoSmithKline  ICOS  Impax Pharmaceuticals  Johnson & Johnson  Novartis  Odyssey/Indevus Pharmaceuticals  Pfizer  Roche  Schwarz Pharma  Watson Pharmaceuticals  Yamanouchi Pharma America

7. © Copyright 2004 Frost & Sullivan. All Rights Reserved.  Call toll free 877 GO FROST (877.463.7876)  Fax toll free 888.690.3329  E-mail myfrost@frost.com  Visit www.frost.com For More Information